News
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
16h
Zacks Investment Research on MSNHims & Hers Health, Inc. (HIMS) is a Great Momentum Stock: Should You Buy?Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even ...
CEO Andrew Dudum said the funds will allow the company to grow internationally and invest in artificial intelligence.
5d
Zacks Investment Research on MSNIs Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now?Hims & Hers Health, Inc. (HIMS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look ...
Shares of Hims & Hers have gained 29% over the past week. The move higher has been driven by an impressive Q1 earnings report ...
Hims & Hers Health Inc (NYSE:HIMS) shares are falling Thursday morning after the company announced a proposed convertible ...
Hims & Hers stock has risen by 20% after announcing a partnership to sell the popular weight-loss drug Wegovy.
The company reported adjusted earnings per share of $0.28 on revenue of $586 million – a significant rise compared to last ...
StockStory.org on MSN11d
Hims & Hers Health Earnings: What To Look For From HIMSTelehealth company Hims & Hers Health (NYSE:HIMS) will be reporting results tomorrow after the bell. Here’s what investors ...
Hims & Hers Health first-quarter revenue more than doubled as subscribers rose 38%, while its second-quarter sales outlook ...
Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after ...
Hims & Hers delivered impressive Q1 2025 results, with 111% y/y revenue growth and 38% y/y subscriber growth. Check out why I ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results